Evidence map›Paper›PMID 27129288›Full record

ArticleBioscience reports2016

Iron-chelating agent desferrioxamine stimulates formation of neutrophil extracellular traps (NETs) in human blood-derived neutrophils.

Lena Völlger, Kathryn Akong-Moore, Linda Cox, Oliver Goldmann, Yanming Wang, Simon T Schäfer, Hassan Y Naim, Victor Nizet, Maren von Köckritz-Blickwede

Open access · goldAbstract read
In one paragraph

Article in Bioscience reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Iron metabolism in rheumatic diseases.Journal of translational autoimmunity · 2025
    Review
  6. Review
  7. Review
  8. Circulating Iron in Patients with Sickle Cell Disease Mediates the Release of Neutrophil Extracellular Traps.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
    Article
  9. Review
  10. Article
  11. Review
  12. Iron Metabolism and Immune Regulation.Frontiers in immunology · 2022
    Review
  13. Review
  14. Review
  15. The impact of metal availability on immune function during infection.Trends in endocrinology and metabolism: TEM · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Identification of a Novel HIF-1α-αFrontiers in immunology · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Lena VöllgerDepartment of Physiological Chemistry, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.
Kathryn Akong-MooreDepartment of Pediatrics, UCSD School of Medicine, San Diego, La Jolla, CA 9500, U.S.A.
Linda CoxKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen, Universität Duisburg-Essen, 45147 Essen, Germany Institut für Physiologie, Universität Duisburg-Essen, 45147 Essen, Germany.
Oliver GoldmannInfection Immunology Group, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany.
Yanming WangCenter for Eukaryotic Gene Regulation, Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA 16802, U.S.A.
Simon T SchäferKlinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen, Universität Duisburg-Essen, 45147 Essen, Germany Institut für Physiologie, Universität Duisburg-Essen, 45147 Essen, Germany.
Hassan Y NaimDepartment of Physiological Chemistry, University of Veterinary Medicine Hannover, 30559 Hannover, Germany.
Victor NizetDepartment of Pediatrics, UCSD School of Medicine, San Diego, La Jolla, CA 9500, U.S.A. Skaggs School of Pharmacy & Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA 92093, U.S.A.
Maren von Köckritz-BlickwedeDepartment of Physiological Chemistry, University of Veterinary Medicine Hannover, 30559 Hannover, Germany Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, 30559 Hannover, Germany maren.von.koeckritz-blickwede@tiho-hannover.de.
University of Veterinary Medicine Hannover, Foundation · DEUniversity of Duisburg-Essen · DEHelmholtz Centre for Infection Research · DE

Funding

Vaccines and Therapies Against BotulismU54AI057153 · NIAID · UNIVERSITY OF CHICAGO · PI SCHLESINGER, LARRY S. · 2003 to 2013
$87.6M
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant InfectionsR01AI093451 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JOHNSON, RANDALL SCOTT, NIZET, VICTOR · 2011 to 2015
$4.9M
NIAID NIH HHS R01 AI093451NIAID NIH HHS U54 AI057153
6 · The paper itself

Abstract

Neutrophil extracellular trap (NET) formation is a significant innate immune defense mechanism against microbial infection that complements other neutrophil functions including phagocytosis and degranulation of antimicrobial peptides. NETs are decondensed chromatin structures in which antimicrobial components (histones, antimicrobial peptides and proteases) are deployed and mediate immobilization of microbes. Here we describe an effect of iron chelation on the phenotype of NET formation. Iron-chelating agent desferrioxamine (DFO) showed a modest but significant induction of NETs by freshly isolated human neutrophils as visualized and quantified by immunocytochemistry against histone-DNA complexes. Further analyses revealed that NET induction by iron chelation required NADPH-dependent production of reactive oxygen species (ROS) as well as protease and peptidyl-arginine-deiminase 4 (PAD4) activities, three key mechanistic pathways previously linked to NET formation. Our results demonstrate that iron chelation by DFO contributes to the formation of NETs and suggest a target for pharmacological manipulation of NET activity.

Indexed as

Cells, CulturedDeferoxamineExtracellular TrapsHumansImmunity, InnateIron Chelating AgentsNeutrophilsPeptide HydrolasesProtein-Arginine DeiminasesProtein-Arginine Deiminase Type 4Reactive Oxygen SpeciesDeferoxamineIron Chelating AgentsPADI4 protein, humanPeptide HydrolasesProtein-Arginine DeiminasesProtein-Arginine Deiminase Type 4Reactive Oxygen Speciesextracellular trapsinnate immunityneutrophils

Identifiers

PMID27129288
PMCPMC5293572
OpenAlexW2313259589

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.